Smart pill to check gut health in colon inflammation and cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a smart pill that measures gut health in people with colon inflammation (ulcerative colitis) or colon cancer. It aims to see if the pill can help doctors better understand how the gut is working during treatment or before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a bowel movement at least once every 48 hours
- If you have ulcerative colitis, you must have moderate to severe active disease starting or changing treatment
- If you have colon cancer, you must be scheduled for surgery and the tumor should not be blocking the bowel
- You must not have a pacemaker or other electronic implant
- You must not be pregnant, breastfeeding, or trying to get pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to check inflammation in people with active IBD using non-invasive devices (like a smartwatch or sensor). It aims to find a simpler method than blood tests or stool samples, which could help manage your condition more easily.
This study tests whether digital tools, like a smartphone app and a wearable activity tracker, can help monitor your inflammatory bowel disease (IBD). You would use these tools and answer questionnaires to help doctors better understand your condition.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This trial tests whether a camera capsule can detect problems in the large intestine when certain gut bacteria are found in the blood. If you have one of these bacteria and are stable enough for the exam, it might help identify the source of the infection.
This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.
This study uses a special camera capsule to map the gut's natural bacteria in people with ulcerative colitis or Crohn's disease, compared to healthy volunteers. The goal is to better understand how these bacteria affect the disease, which could lead to better treatments.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.